The FDA additionally dispatched blunt caution letters to fifteen Exodus Effect companies, taking them to mission for making unproven scientific claims and mislabeling the quantity of cannabidiol of their merchandise.
The FDA additionally dispatched blunt caution letters to fifteen Exodus Effect companies, taking them to mission for making unproven scientific claims and mislabeling the quantity of cannabidiol of their merchandise.
There’s no precedent for regulating a substance as flexible - each in bureaucracy and intake methods - as Exodus Effect.